register

News - Pharmaceuticals

Amazon Australia to disrupt community pharmacy model

Health Industry Hub | January 20, 2020 |

The Australian arm of retail giant Amazon has filed a trademark for the term “Amazon Pharmacy” suggesting a potential entry to the highly regulated pharmaceuticals industry.

Submitted to trademark authority IP Australia in January 2020 the submission covers a number of goods and services classes in the pharmacy space, including medical apparatuses, medication dispensers, online pharmacy retailing and the distribution of prescription medication.

The trademark includes a pharmacy packaging service that aligns, sorts and packages a patient’s medications by date and time into individual packets.

This is similar to Amazon’s existing pharmacy retail service in the US initiated last year through a $1.35 billion acquisition of online pharmacy startup PillPack.

Enhance your business visibility, maximise reach and differentiate your brand. Health Industry Hub is the only one-stop-hub connecting your business to Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our unique media solutions.

PillPack offers pre-sorted medication packages containing individual daily doses, primarily aimed at users who take numerous drugs. The company co-ordinates with doctors and insurers to manage prescriptions, with licensed pharmacists overseeing the process.

A slice of the $38 billion local pharmaceutical sector could be hard going for a new entrant such as Amazon, with Australia having strict rules on who can own pharmacies and how prescriptions must be processed. Pharmacies in Australia must be owned by a pharmacist, and legislation exists which dictates how close a new store can be to an existing pharmacy.

It’s unlikely Amazon would be able to significantly undercut medicine prices, with the government’s Pharmaceutical Benefits Scheme (PBS) limiting the amount Australians pay for most medications. Pharmacists are only able to discount the price by $1, leaving little room for Amazon to offer cheaper rates on prescription medicines as it does for other consumer goods.

To have medication fulfilled online, patients must currently mail their paper prescriptions to the pharmacy first, however, the Department of Health is currently investigating electronic prescription methods providing the legislative framework for prescribers and their patients to have the option to use an electronic prescription as an alternative to a paper-based prescription. When e-prescribing comes in and online pharmacy becomes part of the landscape, up to 20% of the community pharmacy marketshare may become eroded.

The Pharmacy Guild of Australia has brushed off Amazon’s potential entrance into the market, saying Australians prefer to have their prescriptions filled face to face.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

“Australia’s pharmacy network model and regulatory requirements around the supply of prescription medicines has meant most people continue to source their medicines from their local pharmacy where they can get face-to-face advice and assistance,” a Guild spokesperson said.

“Most Australians live within 2.5 km of a local pharmacy, where they can access subsidised medicines immediately – without waiting for a delivery from overseas.”

While Amazon Pharmacy may not happen immediately, there is a real potential for Amazon Australia to disrupt the Australian community pharmacy business in the near future.

You may also like Medicines Australia provides support for bushfire-affected communities


News - MedTech & Diagnostics

Hearts4heart takes aim at private system leaving patients to pay the price

Hearts4heart takes aim at health insurers leaving patients to pay the price

Health Industry Hub | September 4, 2026 |

Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]

More


News - MedTech & Diagnostics

Queensland first: Private hospital deploys Abbott's PFA in atrial fibrillation

Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation

Health Industry Hub | September 4, 2026 |

More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]

More


News - Pharmaceuticals

Five years of HTA reform talk, Now comes the $47 billion question

Five years of HTA reform talk, now comes the $47 billion question

Health Industry Hub | September 4, 2026 |

Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]

More


News - Pharmaceuticals

New MFN deals raise the stakes for Australia’s delayed HTA reform

New MFN deals raise the stakes for Australia’s delayed HTA reform

Health Industry Hub | September 2, 2026 |

Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]

More


This content is copyright protected. Please subscribe to gain access.